Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.

Also called NCT03990480

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 230 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03990480
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03990480. Randomized; no masking; primary purpose treatment. Start 2018-12-01 (actual); primary completion 2019-04-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
Condition
Hypertension
Intervention (Drug)
valsartan (160 mg/d)
Intervention (Drug)
amlodipine (10 mg/d).
Lead sponsor
Damanhour University (class: other)
Collaborator
Tanta University (class: other)

Record details

Record id
cardio:ct-nct03990480
Content hash
f6085a3743c2594e8926c516ad9c1d0b0fed5d818edc8aa8a6846998b1fcc18e